December 13, 2022 Nimble Therapeutics Delivers Lead Compounds for Two Programs Under Collaboration with Large Pharma Partner, Triggering Milestone Payments MADISON, WI, USA, December 13, 2022 — Nimble Therapeutics Inc., a leading peptide therapeutics company, today announced they have achieved
November 30, 2022 Nimble Therapeutics names Pete Gough as Chief Scientific Officer Madison, Wisconsin, November 30th, 2022 – Nimble Therapeutics, an industry-leading peptide therapeutics company, today announced the appointment of Pete Gough,
October 24, 2022 Telegraph Hill Partners Appoints Raymond Falci as Venture Partner October 24, 2022 | For Immediate Release Former Healthcare Research Analyst and Investment Banker Expands Firm’s Operational Depth and Sector
July 1, 2022 Telegraph Hill Partners Raises $525M Fifth Fund for New Life Science and Healthcare Investments San Francisco, June 30, 2022 – Telegraph Hill Partners (THP), a venture capital and growth equity firm dedicated to building
June 28, 2022 Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic The OncoSignature® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely to
June 14, 2022 MOSAIC BIOSCIENCES SECURES FINANCING FROM TELEGRAPH HILL PARTNERS TO SUPPORT COMMERCIAL GROWTH AND EXPAND DRUG DISCOVERY CAPABILITIES AND SERVICES Boulder, CO: Mosaic Biosciences (“Mosaic” or “the Company”), a protein and antibody discovery company that helps its partners identify next-generation
May 17, 2022 Nimble Therapeutics Announces Achievement of Development Milestones from Multiple Partnered Programs Connected to a Strategic Large Pharma Collaboration MADISON, WI, USA, [05/17/2022] — Nimble Therapeutics Inc. today announced the company has achieved the first development milestone for each
April 13, 2022 bioMérieux strengthens its commitment to fight antimicrobial resistance with the acquisition of Specific Diagnostics, an innovative company focusing on fast AST solution Marcy l’Étoile, France, April 12th 2022 – bioMérieux, a world leader in the field of in vitro diagnostics, announces that
January 25, 2022 AmerisourceBergen and TrakCel Launch Integrated Platform to Support Cell and Gene Therapies The integration of TrakCel’s OCELLOS and Lash Group’s Fusion aims to improve speed-to-therapy by increasing connectivity between providers and hub
January 25, 2022 Excellos Launches to Accelerate Innovation in the Cell and Gene Therapy Industry Founded by an Experienced Management Team and Built on the Reach and Infrastructure of the San Diego Blood Bank